ArticleClinical and experimental medicine2024

Immune checkpoint inhibitors and risk of immune-mediated adverse events: a cohort study comparing extended versus standard interval administration.

Amélia Lessard-Roy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.